BMRN ▲ +0.5% - BioMarin Pharmaceutical Inc. $BMRN BMRN - BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors BioMarin Pharmaceutical rose 0.5% following its announcement that Robert Plenge, Chief Research Officer at Bristol Myers Squibb, has joined the company's board of directors. The appointment adds deep pharmaceutical research and development expertise to BioMarin's leadership as the biotech company continues advancing its pipeline of rare disease treatments. 14-SEP-2026 09:06 AM ET